Insider trades

Lyons Gary A

Lyons Gary A made 0 buys and 10 sales on the open market in the last 12 months at Neurocrine Biosciences, Inc. and Travere Therapeutics, Inc. Each trade with the role, price and filing.

DateCompanyTradeSharesPrice
Nov 17, 2026Neurocrine Biosciences, Inc.Sale1,200US$163.11
Nov 17, 2026Neurocrine Biosciences, Inc.Sale4,011US$163.94
Nov 17, 2026Neurocrine Biosciences, Inc.Sale5,689US$165.15
Nov 17, 2026Neurocrine Biosciences, Inc.Sale4,100US$165.90
Aug 18, 2026Travere Therapeutics, Inc.Sale900US$63.86
Aug 18, 2026Travere Therapeutics, Inc.Sale4,100US$63.27
Aug 17, 2026Travere Therapeutics, Inc.Sale500US$64.16
Aug 17, 2026Travere Therapeutics, Inc.Sale1,900US$62.53
Aug 17, 2026Travere Therapeutics, Inc.Sale2,600US$63.50
Apr 14, 2026Travere Therapeutics, Inc.Sale8,000US$41.07